Article Text

Download PDFPDF

Covered stents may provide extra protection during carotid artery stenting in high risk patients with an excessive thrombus burden
  1. Ersan Tatli1,
  2. Ahmet Barutcu2,
  3. Emine Gazi2,
  4. Yasemin Gunduz3
  1. 1Department of Cardiology, Ada Tıp Hospital, Sakarya, Turkey
  2. 2Department of Cardiology, Onsekiz Mart University Hospital, Çanakkale, Turkey
  3. 3Department of Radiology, Sakarya University Hospital, Sakarya, Turkey
  1. Correspondence to Professor Ersan Tatli, ersantatli{at}


Carotid artery disease is an important cause of mortality and morbidity related to atherosclerosis. Recently, percutaneous intervention procedures have been widely used to treat atherosclerotic carotid artery disease. We report the case of a 57-year-old male patient with a history of acute amaurosis fugax. Carotid angiography was performed as blood pressure differed between his left and right arms and there was a pan-systolic murmur on the left common carotid artery. Total occlusion of the proximal right brachiocephalic artery and a thrombus occluding 90–99% of the left internal carotid artery were detected by carotid angiogram. A self-expanding graft-covered stent was successfully implanted and there were no complications. This case shows that graft-covered stents may be a good alternative technique in special situations.

View Full Text

Statistics from


Atherosclerotic carotid artery disease is one of the most important causes of cerebrovascular adverse events and in developed countries is the most common cause of mortality and morbidity after coronary artery disease and malignancy. Carotid artery stenting (CAS) is the preferred therapy. As embolism formation is the most important complication of CAS, embolism protection techniques and devices are required during the procedure. In this case report, we described an alternative approach for reducing embolism formation through the use of covered stents in a patient with severe carotid artery disease.

Case presentation

A 57-year-old male patient presented with a history of acute amaurosis fugax. He had a history of previous myocardial infarction, diabetes mellitus and hypertension. On physical examination, his blood pressure was 70/40 mm Hg in the right and 160/90 mm Hg in the left arm. There was a 3/6 pan-systolic murmur on the left common carotid artery.


Carotid angiography demonstrated total occlusion of the proximal right brachiocephalic artery. In addition, a thrombus occluded 90–99% of the left internal carotid artery (LICA). Cerebral perfusion was totally dependent on the left carotid artery system (figures 1 and 2). LICA stenting was the chosen therapy but brain perfusion needed to be protected. The right common carotid artery occlusion meant a proximal blocking-based protection system could not be used as there was a high probability of embolism formation from the thrombus on the blocking lesion.

Figure 1

Carotid angiogram shows total occlusion of the right brachiocephalic artery and cranial perfusion.

Figure 2

Left carotid angiogram shows a thrombus in the left internal carotid artery.


We decided to place a graft-covered stent through the lesion first, and contain the plaque and thrombus between the stent and the lumen. Therefore, a graft covered stent (5×13, Direct) was implanted with 12 atm pressure. After removing the distal blocking-based protection system, we opened the self-expanding stent (7×10×30, Cristallo) (figure 3) and dilated the stent using a post-dilatation balloon (5×20, Tarcomgrande). The procedure was completed successfully and there were no complications (figure 4).

Figure 3

Stenting of the left internal carotid artery with a graft-covered stent.

Figure 4

Left carotid angiogram shows no residual stenosis after stenting.

Outcome and follow-up

Control Doppler ultrasonography examinations at 1 and 6 months after the procedure showed no evidence of restenosis nor were there any clinical sign of restenosis.


CAS is used frequently for the treatment of carotid artery stenosis.1 ,2 Most CAS-related complications occur as a result of embolism formation. The most embologenic phases of the CAS procedure are the pre-dilatation, stent deployment and post-dilatation stages.3 The use of protection devices has been associated with a reduced rate of neurological complications4 but may actually increase the number of emboli and cannot prevent post-procedural embolism formation.5

An alternative approach to reducing embolisms may be through the use of covered stents. A covered stent, in which the stent mesh is coated with a thin membrane, may prevent the passage of atherosclerotic material through the stent grid. We have proposed that covered stents efficiently reduce embolism formation during stent deployment, post-dilatation and post-procedurally.

Graft-covered stents contain the atherosclerotic and embolic materials between the vessel wall and the stent itself, thus reducing embolic events. Schillinger et al6 followed 14 patients with carotid stenosis for 6 months. Graft-covered stents had been implanted in eight of these patients and bare stents in six. There were fewer embolic events during and after the procedure in the graft-covered than the bare stent group, but restenosis was observed in three of the patients in the graft-covered stent group. Cil et al7 employed graft-covered stents in three patients with carotid artery stenosis without the use of protection devices; no restenosis was observed at 6-month follow-up. In contrast to the cases described in the literature, we used a self-expanding graft-covered stent.

Our experience indicates that graft-covered stents may be a good option when a proximal filter blocking system cannot be used due to the tortuous structure of the vessel.

Learning points

  • Carotid artery stenting is the preferred treatment for atherosclerotic carotid artery disease but may result in embolism formation.

  • The use of protection devices has been associated with a reduced rate of neurological complications but they do not prevent post-procedural embolism formation.

  • Graft-covered stents may reduce embolic events and are a good alternative technique to prevent embolism formation.


View Abstract


  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.